Skip to main content
Book cover

Mouse Liver Tumors

Relevance to Human Cancer Risk Symposium of the European Society ofToxicology Held in Rome, February 2–5, 1986

  • Conference proceedings
  • © 1987

Overview

Part of the book series: Archives of Toxicology (TOXICOLOGY, volume 10)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (25 papers)

  1. Introduction

  2. Molecular Basis

Keywords

About this book

Peroxisome proliferation in the liver parenchymal cells is frequently observed in rats and mice exposed to certain xenobiotic compounds. Hepatic peroxisome pro­ liferation was first noted nearly twenty years ago in the livers of rats treated with the hypolipidemic drug clofibrate (Hess et aI. , 1965; Svoboda and Azarnoff, 1966). Subsequently, several structurally unrelated hypolipidemic compounds were found to induce marked hepatomegaly and hepatic peroxisome proliferation in rats and mice, which led to the suggestion of a possible relationship between peroxisome proliferation and lipid metabolism (Reddy and Krishnakantha, 1975) as well as to the identification of a peroxisomal fatty acid f3-oxidation enzyme sys­ tem in the rat liver (Lazarow and DeDuve 1976). A second major class of per ox i­ some proliferators was identified nearly ten years ago, with the discovery that the dietary administration of a widely used phthalate-ester plasticizer di(2-ethylhex­ yl)phthalate (DEHP) to rats, results in the induction of peroxisomal enzymes in liver (Reddy et aL 1976a). Hypolipidemic drugs and phthalate-ester plasticizers constitute two major and important categories of chemicals with profound peroxisome proliferative property (Reddy et aL 1982; Reddy and Lalwani 1983). These two classes of xenobiotics now have important roles. First, the hypolipi­ demic drugs are increasingly used in the control of hyperlipidemia, a major risk factor for developing coronary heart disease.

Editors and Affiliations

  • Department of Pharmacology and Therapeutics, Trinity College, University of Dublin, Dublin 2, Ireland

    Philip L. Chambers

  • Institut für Toxikologie und Pharmakologie, der Universität Würzburg, Würzburg, Germany

    Dietrich Henschler

  • Institut für Toxikologie, der Universität Mainz, Mainz, Germany

    Franz Oesch

Bibliographic Information

  • Book Title: Mouse Liver Tumors

  • Book Subtitle: Relevance to Human Cancer Risk Symposium of the European Society ofToxicology Held in Rome, February 2–5, 1986

  • Editors: Philip L. Chambers, Dietrich Henschler, Franz Oesch

  • Series Title: Archives of Toxicology

  • DOI: https://doi.org/10.1007/978-3-642-71617-1

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1987

  • Softcover ISBN: 978-3-540-17124-9Due: 01 January 1987

  • eBook ISBN: 978-3-642-71617-1Published: 06 December 2012

  • Series ISSN: 0171-9750

  • Edition Number: 1

  • Number of Pages: VI

  • Number of Illustrations: 18 b/w illustrations

  • Topics: Pharmacology/Toxicology, Oncology, Pharmacy

Publish with us